(Q52932701)
Statements
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. (English)
1 reference
Corinna Leng
1 reference
Margarethe Gries
1 reference
Judy Ziegler
1 reference
Anna Lokshin
1 reference
Paolo Mascagni
1 reference
Suzanne Lentzsch
1 reference
Markus Y Mapara
1 reference
1 June 2006
1 reference
34
1 reference
6
1 reference
776-787
1 reference